The study aims to investigate gender-specific adaptations to beta2-adrenoceptor stimulation with selective short- and long-acting beta2-agonist with emphasis on skeletal muscle in relation to performance enhancing effects and anti-doping
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Enrollment
72
Subjects are treated with daily inhalation of formoterol
Subjects are treated with daily inhalation of terbutaline
Subjects are treated with placebo
August Krogh Building
Copenhagen, Denmark
RECRUITINGProteome enrichment
Change in enrichment (measured in muscle biopsies and assessed using GO annotations)
Time frame: Baseline and 6 weeks
Body composition
Change in body composition (measured by dual energy x ray absorptiometry)
Time frame: Baseline, 2 weeks, 4 weeks and 6 weeks
Maximal oxygen consumption (VO2max)
Change in VO2max (measured during bike ergometer cycling to exhaustion)
Time frame: Baseline, 2 weeks, 4 weeks and 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.